Conversely, Salvesen and colleagues (27) showed that loss of nuclear p16 was associated with poor tumor characteristics including, advanced stage, serous or clear cell histology, poorly differentiated tumors, and worse survival. This evidence concerns the gene CDKN2A and neoplasm.